Small renal carcinoma : the "when" and "how" of operation, active surveillance, and ablation

2018
journal article
article
3
cris.lastimport.wos2024-04-10T02:57:09Z
dc.abstract.enSmall, locally restricted renal cell carcinoma less than 4 cm in size should ideally be removed operatively by nephron-sparing tumour enucleation (partial kidney resection). In an increasingly elderly population, there is a growing trend toward parallel incidence of renal cell carcinoma and chronic renal insufficiency, with the latter's associated general comorbidities. Thus, for some patients, the risks of the anaesthesia and operation increase, while the advantage in terms of survival decreases. Transcutaneous radio-frequency ablation under local anaesthesia, transcutaneous afterloading high-dose-rate brachytherapy under local anaesthesia, and percutaneous stereotactic ablative radiotherapy may offer a less invasive alternative therapy. Active surveillance is to be regarded as no more than a controlled bridging up to definitive treatment (operation or ablation), while watchful waiting, on account of the lack of prognostic relevance and the symptomatology of renal cell carcinoma, with its comorbidity-related, clearly reduced life expectancy, does not involve any further diagnostic or therapeutic measures.pl
dc.contributor.authorWendler, Jakob Johannpl
dc.contributor.authorLiehr, Bernd Uwepl
dc.contributor.authorDamm, Robertpl
dc.contributor.authorPowerski, Maciejpl
dc.contributor.authorBrunner, Thomaspl
dc.contributor.authorSchostak, Martinpl
dc.contributor.authorPech, Maciejpl
dc.date.accessioned2019-02-15T13:10:52Z
dc.date.available2019-02-15T13:10:52Z
dc.date.issued2018pl
dc.date.openaccess0
dc.description.accesstimew momencie opublikowania
dc.description.additionalBibliogr. s. e566-e568pl
dc.description.physicale561-e568pl
dc.description.versionostateczna wersja wydawcy
dc.description.volume83pl
dc.identifier.doi10.5114/pjr.2018.81282pl
dc.identifier.eissn1899-0967pl
dc.identifier.issn1733-134Xpl
dc.identifier.projectROD UJ / OPpl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/68492
dc.languageengpl
dc.language.containerengpl
dc.rightsUdzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa*
dc.rights.licenceCC-BY-NC-ND
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl*
dc.share.typeotwarte czasopismo
dc.subject.enrenal cell carcinomapl
dc.subject.ensmall renal tumourpl
dc.subject.enactive surveillancepl
dc.subject.enablationpl
dc.subject.enfocal therapypl
dc.subtypeArticlepl
dc.titleSmall renal carcinoma : the "when" and "how" of operation, active surveillance, and ablationpl
dc.title.journalPolish Journal of Radiologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-10T02:57:09Z
dc.abstract.enpl
Small, locally restricted renal cell carcinoma less than 4 cm in size should ideally be removed operatively by nephron-sparing tumour enucleation (partial kidney resection). In an increasingly elderly population, there is a growing trend toward parallel incidence of renal cell carcinoma and chronic renal insufficiency, with the latter's associated general comorbidities. Thus, for some patients, the risks of the anaesthesia and operation increase, while the advantage in terms of survival decreases. Transcutaneous radio-frequency ablation under local anaesthesia, transcutaneous afterloading high-dose-rate brachytherapy under local anaesthesia, and percutaneous stereotactic ablative radiotherapy may offer a less invasive alternative therapy. Active surveillance is to be regarded as no more than a controlled bridging up to definitive treatment (operation or ablation), while watchful waiting, on account of the lack of prognostic relevance and the symptomatology of renal cell carcinoma, with its comorbidity-related, clearly reduced life expectancy, does not involve any further diagnostic or therapeutic measures.
dc.contributor.authorpl
Wendler, Jakob Johann
dc.contributor.authorpl
Liehr, Bernd Uwe
dc.contributor.authorpl
Damm, Robert
dc.contributor.authorpl
Powerski, Maciej
dc.contributor.authorpl
Brunner, Thomas
dc.contributor.authorpl
Schostak, Martin
dc.contributor.authorpl
Pech, Maciej
dc.date.accessioned
2019-02-15T13:10:52Z
dc.date.available
2019-02-15T13:10:52Z
dc.date.issuedpl
2018
dc.date.openaccess
0
dc.description.accesstime
w momencie opublikowania
dc.description.additionalpl
Bibliogr. s. e566-e568
dc.description.physicalpl
e561-e568
dc.description.version
ostateczna wersja wydawcy
dc.description.volumepl
83
dc.identifier.doipl
10.5114/pjr.2018.81282
dc.identifier.eissnpl
1899-0967
dc.identifier.issnpl
1733-134X
dc.identifier.projectpl
ROD UJ / OP
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/68492
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Udzielam licencji. Uznanie autorstwa - Użycie niekomercyjne - Bez utworów zależnych 4.0 Międzynarodowa
dc.rights.licence
CC-BY-NC-ND
dc.rights.uri*
http://creativecommons.org/licenses/by-nc-nd/4.0/legalcode.pl
dc.share.type
otwarte czasopismo
dc.subject.enpl
renal cell carcinoma
dc.subject.enpl
small renal tumour
dc.subject.enpl
active surveillance
dc.subject.enpl
ablation
dc.subject.enpl
focal therapy
dc.subtypepl
Article
dc.titlepl
Small renal carcinoma : the "when" and "how" of operation, active surveillance, and ablation
dc.title.journalpl
Polish Journal of Radiology
dc.typepl
JournalArticle
dspace.entity.type
Publication
Affiliations

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
7
Views per month
Views per city
Hong Kong
4
Ashburn
2
Downloads
wendler_liehr_damm_powerski_brunner_schostak_pech_small_renal_carcinoma_the_'when'_and_'how'_of_operation_2018.odt
86
wendler_liehr_damm_powerski_brunner_schostak_pech_small_renal_carcinoma_the_'when'_and_'how'_of_operation_2018.pdf
6